Irrespective of the severity of the condition, we always offer patients the best possible cancer treatment while also focusing on quality of life.
Treating doctors and pharmacists are guaranteed our all-round, flexible and dependable service, along with advice on practical issues and decisions related to health policy.
We are glad to provide doctors and pharmacists with support, which includes the introduction of quality management systems and certification processes.
Use our commitment and our expertise to your own advantage!
Founding year of Bendalis GmbH with headquarters in Oberhaching, near Munich.
Market launch of Bendafolin® (folinic acid).
Dr Reinhold A. Kudielka joins as executive partner in marketing & sales.
Market launch of five oncology products:
- 5-fluorouracil (5-FU)
Collaboration with EUSA Pharma GmbH in the distribution of Caphosol® for treating oral mucositis.
Expansion of the product portfolio with six generic oncology drugs:
Collaboration with Riemser Arzneimittel AG in the distribution of ALOXI®, an innovative 5-HT3 receptor antagonist for the prophylaxis of chemotherapy-induced nausea and vomiting.
Expansion of the product portfolio to include the supportive care product range, AgainLife Italia:
- OraLife – mouth and throat
- TraLife – throat
- RaLife – skin
- EvaLife – genital region
- GutLife – anal region
Expansion of the product portfolio to include two generic oncology drugs:
- Zoledronic acid
- Ibandronic acid
Expansion of the supportive care product portfolio: KapDolen 30 ml – to alleviate damaged tissue and nerve fibres
Expansion of the supportive care product portfolio: KapDolen 100 ml – to alleviate damaged tissue and nerve fibres